Authors: Gulbrandsen, N Wisloff, F Brinch, L Carlson, K Dahl, IM Gimsing, P Hippe, E Hjorth, M Knudsen, LM Lamvik, J Lenhoff, S Lofvenberg, E Nesthus, I Nielsen, JL Turesson, L Westin, J

Citation: N. Gulbrandsen et al., Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support, MED ONCOL, 18(1), 2001, pp. 65-77

Authors: Lenhoff, S Hjorth, M Holmberg, E Turesson, I Westin, J Nielsen, JL Wisloff, F Brinch, L Carlson, K Carlson, M Dahl, IM Gimsing, P Hippe, E Johnsen, H Lamvik, J Lofvenberg, E Nesthus, I Rodjer, S

Citation: S. Lenhoff et al., Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study, BLOOD, 95(1), 2000, pp. 7-11

Authors: Foss, B Nesthus, I Bergheim, J Bruserud, O

Citation: B. Foss et al., Serum levels of thrombopoietin and stem cell factor in acute leukemia patients with chemotherapy-induced cytopenia and complicating infections, PLATELETS, 10(1), 1999, pp. 17-23